Our monthly report on AI, ML, DL, and NLP in healthcare looks at who, what, where, and how the use of artificial intelligence is changing healthcare for the better. We will bring you some of the latest news and product information along with thought leader posts and our AI playlist of episodes from Healthcare NOW Radio.
In the News
Artera Launches with $90 Million in Funding to Personalize Cancer Therapy With Multimodal AI
Artera (@arteraAI), the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, launches publicly with $90M in funding. The investment comes from a syndicate of prominent tech and healthcare investors, comprised of seven institutions (Coatue, Johnson & Johnson Innovation – JJDC, Inc., Koch Disruptive Technologies, Walden Catalyst Ventures, TIME Ventures, Breyer Capital, The Factory) and 11 angel investors (Marc Benioff, Jim Breyer, Lip-Bu Tan, Chris Re, Andy Jacques, Amarjit Gill, Jeff Dean, Steve Blank, Dennis Wong, Clarence So, Michael Driscoll).
Zephyr AI and KangarooHealth Announce Partnership to Harness the Power of Remote Patient Monitoring and Artificial Intelligence
Zephyr AI, Inc. (@zephyr_ai), a company building novel transparent AI to address unmet needs across the full spectrum of precision medicine—from prevention to treatment to improve patients’ lives and KangarooHealth, Inc. (@Kangaroo_Health), a healthcare technology company providing an AI-assisted turn-key remote patient monitoring platform and care management services, announced a multi-year strategic partnership to work toward providing clinicians with insights to inform treatment decisions for patients diagnosed with chronic conditions.
Care Angel Launches Offering to Support Managed Care Plans Charged with Medicaid Redetermination
Care Angel, an AI digital health engagement company, announces its offering to support health insurers in maximizing outreach efforts to recertify the nation’s estimated 91 million Medicaid members. The company’s offering is announced amidst the unwinding of the public health emergency, which had allowed for the continuous enrollment of members.
Aiberry Secures $8M in Seed Funding to Accelerate AI-Powered Mental Health Screenings
Artificial intelligence (AI)-powered mental health screening pioneer Aiberry (pronounced “I” + “berry”) announced that it has secured $8 million in seed funding led by Confluence Capital Group, Inc. (CCG) with participation from the VC fund Ascension AI. The new funds, which bring total funding to $10M, will be used to accelerate adoption of the Aiberry platform, which uses an AI-powered therapeutic assistant to conduct a conversation to detect mental health disorders by analyzing what is being said, the speech patterns being used and even subtle changes in facial expressions.
Transcarent to Acquire 98point6 AI-Powered Virtual Care Platform and Care Business
Transcarent (@transcarent), a health and care experience company that makes it easy for people to access high-quality, affordable care announced plans to acquire the leading AI-powered virtual care platform and care business of on-demand primary care company, 98point6. The acquisition gives Transcarent access to the leading AI-powered virtual care technology and an affiliated medical group of providers skilled at delivering high-quality, on-demand care.
AION Labs Launches AI Startup for De Novo Antibody Design
AION Labs (@AionLabs), the first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced the formation of DenovAI, the lab’s second startup approved by the Israel Innovation Authority. The new company will develop an AI-powered biophysics solution that can discover potential antibodies completely de novo (from scratch), and then suggest candidates likely to make effective drugs.
Vital Announces HITRUST Certification and SOC 2 Type 2 Completion, Furthering Its Commitment to Security and Compliance
Vital, an AI-driven digital health company, announces the company’s completion of both its HITRUST, Risk-based 2-year Certification for implemented systems and its SOC 2 Type 2 report furthering its commitment to security and compliance.
Lark Health’s Artificial Intelligence (AI) Heart Health Program Significantly Improves Cardiac Self-Efficacy
Lark Health (@larkhealth), a digital care company for the prevention and management of chronic conditions, announced key results from its pilot study surrounding its Artificial Intelligence (AI)-powered Heart Health program, which helps patients prevent and manage heart disease by targeting Cardiovascular Disease (CVD) risk factors. The study, “Cardiac Self-Efficacy Improvement in a Digital Health Pilot Program for Heart Health” found that, on average, study participants increased their Cardiac Self-Efficacy (CSE) score by 12.93 percent, the first digital care solution to show CSE improvement. The CSE study results will be presented at The Society of Behavioral Medicine’s 44th Annual Meeting & Scientific Sessions in Phoenix, AZ, from April 26–29, 2023.
Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm
Viz.ai (@viz_ai), a company in AI-powered disease detection and intelligent care coordination, announced it has received U.S. Food and Drug Administration (FDA) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA). Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected AAA.
Etiometry Announces CE Mark and Health Canada Authorization for Adult Use of AI-Based Algorithm that Detects Risk of Hypercapnia
Etiometry (@etiometry), a company in clinical decision-support software for critical care, announced CE Mark and Health Canada authorization of its IVCO2 Index™ for adult populations, which allows clinicians to visualize inadequate ventilation of carbon dioxide with other contextual data from the Etiometry Platform to help inform intervention decisions and get ahead of patient deterioration. The IVCO2 Index was first FDA-cleared for pediatric use in 2019 and now carries CE Mark and Health Canada licenses for both pediatric and adult use.
Nuance and Microsoft Announce the First Fully AI-Automated Clinical Documentation Application for Healthcare
Nuance Communications, Inc. (@NuanceInc), a Microsoft Company, announced Dragon Ambient eXperience (DAX™) Express, a workflow-integrated, fully automated clinical documentation application that is the first to combine proven conversational and ambient AI with OpenAI’s newest and most capable model, GPT-4. Extending the proven Dragon Medical portfolio of solutions and building on the market-leading DAX ambient solution launched in 2020, DAX Express is the next milestone in Nuance’s long-standing mission to reduce administrative burden and empower clinicians to spend more time taking care of patients and less time on paperwork. DAX Express makes available world-class AI to more than 550,000 Dragon Medical users, is enhanced by GPT-4, and amplified by the power of Microsoft Azure.
ThinkAndor® Leverages Open AI and Healthcare Trained GPT Models to Create the Next Dimension in Virtual Nursing
Andor Health (@andor_health), the company reinventing virtual health as a platform, accelerates Health First’s virtual rounding program by extending the program to support virtual nursing. Physicians and nurses are experiencing burnout leaving health systems overburdened and hospitals at capacity. Due to staffing shortages, hospitals are struggling to admit/discharge patients in a timely matter negatively impacting a patient’s length of stay. Forward-thinking health systems are solving these issues by implementing a unified, scalable virtual health strategy. ThinkAndor® provides a cohesive platform that leverages OpenAI & healthcare trained GPT that help orchestrate clinical workflows and curate appropriate clinical context to meet the rapidly changing needs of health systems.
Eko Launches SENSORA™ Cardiac Disease Detection Platform
Eko (@Eko_Health), a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease, announced the launch of the SENSORA™ Cardiac Disease Detection Platform. SENSORA™ currently features AI that objectively identifies structural murmurs, a sign of valvular heart disease, and Care Pathway Analytics software that provides downstream visibility and metrics of the patient journey through the healthcare system.
HIMSS 23 Preconference Forum
Machine Learning & AI for Healthcare Forum
Monday April 17, 2023 | 8:00 am – 4:30 pm
Fee: $350 Advanced | $400 Standard
Register for this event.
The Machine Learning and AI for Healthcare Forum will offer attendees real world use cases and provide opportunities to network with your fellow ML/AI peers. Sessions include:
- The Ethics of AI in Healthcare
- Building and Evaluating Business Cases for ML/AI in Health
- AI Governance: Frameworks and Technologies
- It Speaks, It Listens, It’s Your Daily Voice Assistant – Leveraging Voice
- Technology in Health and Wellness
- AI Economics – Driving Value at Scale
- 2023 AI in Healthcare: The Good, The Bad and The Hopeful